Last Updated: November 19, 2026

Details for Patent: 8,653,092

« Back to Dashboard


Which drugs does patent 8,653,092 protect, and when does it expire?

Patent 8,653,092 protects JOENJA and is included in one NDA.

This patent has forty-nine patent family members in forty-three countries.

Summary for Patent: 8,653,092
Title:Tetrahydro-pyrido-pyrimidine derivatives
Abstract:The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), wherein Y, R1, R2 and m are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.
Inventor(s):Nigel Graham Cooke, Paulo FERNANDES GOMES DOS SANTOS, Nadege GRAVELEAU, Christina HEBACH, Klemens Högenauer, Gregory Hollingworth, Alexander Baxter Smith, Nicolas Soldermann, Frank Stowasser, Ross Strang, Nicola TUFILLI, Anette Von Matt, Romain Wolf, Frédéric Zecri
Assignee: Novartis AG
Application Number:US13/175,050
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,653,092

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pharming JOENJA leniolisib phosphate TABLET;ORAL 217759-001 Mar 24, 2023 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,653,092

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2590974 ⤷  Start Trial 301386 Netherlands ⤷  Start Trial
European Patent Office 2590974 ⤷  Start Trial CA 2026 00029 Denmark ⤷  Start Trial
European Patent Office 2590974 ⤷  Start Trial C20265013 Finland ⤷  Start Trial
European Patent Office 2590974 ⤷  Start Trial 2026C/725 Belgium ⤷  Start Trial
European Patent Office 2590974 ⤷  Start Trial PA2026527 Lithuania ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.